Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Mabs
|
May 12, 2015
Regulatory considerations in oncologic biosimilar drug development
Judith C Macdonald, Helen Hartman, Ira A Jacobs
Frontiers in Medicine
|
June 10, 2021
Digital Innovation in Medicinal Product Regulatory Submission, Review, and Approvals to Create a Dynamic Regulatory Ecosystem-Are We Ready for a Revolution?
Judith C Macdonald, David C Isom, Daniel D Evans, et al.
Frontiers in Medicine
|
August 11, 2023
Walking the talk in digital transformation of regulatory review
Ramy Khalil, Judith C Macdonald, Andrew Gustafson, et al.
Molecular Therapy. Methods & Clinical Development
|
July 5, 2022
Impact of genetically modified organism requirements on gene therapy development in the EU, Japan, and the US
Gentaro Tajima, Seoan Huh, Natalie Anne Schmidt, et al.
Frontiers in Medicine
|
November 29, 2023
Regulatory agilities impacting review timelines for Pfizer/BioNTech's BNT162b2 mRNA COVID-19 vaccine: a retrospective study
Prisha Patel, Judith C Macdonald, Jayanthi Boobalan, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Mabs
|
May 12, 2015
Regulatory considerations in oncologic biosimilar drug development
Judith C Macdonald, Helen Hartman, Ira A Jacobs
Frontiers in Medicine
|
June 10, 2021
Digital Innovation in Medicinal Product Regulatory Submission, Review, and Approvals to Create a Dynamic Regulatory Ecosystem-Are We Ready for a Revolution?
Judith C Macdonald, David C Isom, Daniel D Evans, et al.
Frontiers in Medicine
|
August 11, 2023
Walking the talk in digital transformation of regulatory review
Ramy Khalil, Judith C Macdonald, Andrew Gustafson, et al.
Molecular Therapy. Methods & Clinical Development
|
July 5, 2022
Impact of genetically modified organism requirements on gene therapy development in the EU, Japan, and the US
Gentaro Tajima, Seoan Huh, Natalie Anne Schmidt, et al.
Frontiers in Medicine
|
November 29, 2023
Regulatory agilities impacting review timelines for Pfizer/BioNTech's BNT162b2 mRNA COVID-19 vaccine: a retrospective study
Prisha Patel, Judith C Macdonald, Jayanthi Boobalan, et al.
Page
of 1